UK markets open in 1 hour 24 minutes

RAPT Therapeutics, Inc. (RAPT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.12-0.06 (-0.67%)
At close: 04:00PM EDT
8.15 +0.02 (+0.31%)
After hours: 06:18PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,283
0
1,527
3,813
5,042
Operating expenses
Research development
61,927
101,002
67,082
56,985
45,485
Selling general and administrative
19,754
26,060
20,240
16,037
12,771
Total operating expenses
81,681
127,062
87,322
73,022
58,256
Operating income or loss
-79,398
-127,062
-85,795
-69,209
-53,214
Total other income/expenses net
582
10,264
1,957
5
1,312
Income before tax
-78,816
-116,798
-83,838
-69,204
-51,902
Income tax expense
-
-
-
0
990
Income from continuing operations
-78,816
-116,798
-83,838
-69,204
-52,892
Net income
-78,816
-116,798
-83,838
-69,204
-52,892
Net income available to common shareholders
-78,816
-116,798
-83,838
-69,204
-52,892
Basic EPS
-2.89
-
-2.58
-2.53
-2.19
Diluted EPS
-2.89
-
-2.58
-2.53
-2.19
Basic average shares
37,671
-
32,540
27,390
24,134
Diluted average shares
37,671
-
32,540
27,390
24,134